Home/Filings/4/0001104659-24-031185
4//SEC Filing

Bastone Bronwen 4

Accession 0001104659-24-031185

CIK 0001868912other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 8:20 PM ET

Size

8.4 KB

Accession

0001104659-24-031185

Insider Transaction Report

Form 4
Period: 2024-03-01
Bastone Bronwen
Chief People Officer
Transactions
  • Award

    Class A Common Stock

    2024-03-01+104,603258,449 total
  • Award

    Class A Common Stock

    2024-03-01$8.67/sh+5,209$45,162263,658 total
  • Tax Payment

    Class A Common Stock

    2024-03-01$8.67/sh1,906$16,525261,752 total
Footnotes (3)
  • [F1]Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The RSUs will vest in full as follows: 8,651, 8,651, 78,651 and 8,650 on each of March 1, 2025, 2026, 2027 and 2028.
  • [F2]Consists of fully vested shares issued under the Plan (the "Vested Shares").
  • [F3]Consists of shares withheld to satisfy tax withholding obligations resulting from delivery of the Vested Shares to the reporting person; not an open market transaction.

Issuer

Enfusion, Inc.

CIK 0001868912

Entity typeother

Related Parties

1
  • filerCIK 0001927636

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 8:20 PM ET
Size
8.4 KB